Natural Killer Cells

Tracking
Effector and Memory NK Cells During MCMV Infection.- Application
of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer
Cells.- Assessment
of NK Cell Metabolism.- Genotyping Single Nucleotide Polymorphisms and
Copy Number Variability of the FCGRs Expressed on NK Cells.- Measurement
of Average Telomere Length in Ex Vivo
Expanded Natural Killer Cells by Fluorescence In Situ Hybridization (FISH).- In
Vitro Assessment of Human Natural Killer Cell Migration and Invasion.- Microfluidic-Based
Live-Cell Analysis of NK-Cell Migration In Vitro.- Microwell-Based
Live Cell Imaging of NK Cell Dynamics to Assess Heterogeneity in Motility and Cytotoxic
Response.- Assessment
of Natural Killer Cell Cytotoxicity Using Image Cytometry Method.- Analysis
of Intracellular Ca2+ Mobilization in Human NK Cell Subsets by Flow Cytometry.- Using NK Cell Lipid Raft Fractionation to Understand
the Role of Lipid Rafts in NK Cell Receptor Signaling.- High-
and Super-Resolution Microscopy Imaging of the NK Cell Immunological Synapse.- The
Planar Lipid Bilayer System Serves as a Reductionist Approach for Studying NK
Cell Immunological Synapses and their Functions.- Expansion
of NK Cells Using Genetically Engineered K562 Feeder Cells.- Ex-Vivo
Expansion of Human NK Cells Using K562 Engineered to Express Membrane Bound
IL21.- Large-Scale
Culture and Genetic Modification of Human Natural Killer Cells for Cellular
Therapy.- Gene
Modification of Human Natural Killer Cells Using a Retroviral Vector.- Modification
of Expanded NK Cells with Chimeric Antigen Receptor mRNA for Adoptive Cellular
Therapy.- mRNA
Transfection to Improve NK Cell Homing to Tumors.- In
Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor through
Differentiation of Gene-Modified Hematopoietic Stem Cells.- Engineering
Receptor Expression on Natural Killer Cells through Trogocytosis.- Electroporation
of siRNA to Silence Gene Expression in Primary NK Cells.- Mouse Xenograft Model for Intraperitoneal Administration
of NK Cell Immunotherapy for Ovarian Cancer.-  Aerosol
Delivery of Interleukin-2 in Combination with Adoptive Transfer of Natural
Killer Cells for the Treatment of Lung Metastasis: Methodology and Effect.- Non-Invasive Imaging of Natural Killer Cell-Mediated
Apoptosis in a Mouse Tumor Model.- Non-Invasive
In Vivo Fluorescence Imaging of NK Cells
in Pre-Clinical Models of Adoptive Immunotherapy.- In Vivo 19F-Magnetic
Resonance Imaging of Adoptively Transferred NK Cells.- Generation
of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells.- Regulatory
Considerations for NK Cells Used in Human Immunotherapy Applications.